Company
Impulse Dynamics
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
1
510(k), De Novo and PMA
Device trials
11
As lead sponsor, any status
Adverse event reports
87
Received Nov 1, 2025 to Nov 19, 2026
Recall records
1
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$312M
3 Form D offerings, 2022 to 2025
Equity
$312M
Stock sold for cash
Debt and convertible notes
$0
Loans and notes sold to investors
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: equity, $84.1M raised of $140M sought, first sale Feb 20, 2025, 20 investors.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
Company details
From the company's latest Form D.
- Legal name
- Impulse Dynamics plc
- Headquarters
- Dublin 2, Ireland
- Incorporated
- Ireland over five years before filing
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Biotechnology
- SEC filer
- CIK 1823293 ↗
Executives, directors and promoters
As listed on the latest Form D.
6 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Impulse Dynamics.
Latest FDA decisions
- OPTIMIZER Smart SystemBreakthroughPMA
P180036 · Decided Mar 21, 2019 · 197 days after receipt
Device type: Implantable pulse generator (QFV) · Cardiology
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Assessment of Combined CCM and ICD Device in HFrEFActive, not recruiting
NCT05855135 · 300 participants (planned) · Start May 17, 2023 · Primary completion Dec 31, 2025
Device: OPTIMIZER® Integra CCM-D System (Treatment Arm) · For: Heart Failure; Heart Failure With Reduced Ejection Fraction; Implantable Defibrillator User and 7 more
Sites: Glendale, Arizona; Mesa, Arizona; Phoenix, Arizona · 59 sites in all
- Assessment of CCM in HF With Higher Ejection FractionPivotal-lookingRecruiting
NCT05064709 · 1,500 participants (planned) · Start Feb 3, 2022 · Primary completion Feb 1, 2029
Device: Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System; OPTIMIZER™ Smart Mini System · For: Heart Failure; Heart Failure With Preserved Ejection Fraction; Heart Failure With Mid Range Ejection Fraction and 2 more
Sites: Birmingham, Alabama; Mesa, Arizona; Scottsdale, Arizona · 67 sites in all
NCT07209098 · 4,200 participants (planned) · Start Nov 18, 2025 · Primary completion Oct 2030
Device: Cardiac Contractility Modulation (CCM) · For: Heart Failure and Reduced Ejection Fraction; NYHA Class III Heart Failure
Sites: Marlton, New Jersey
8 more trials with a free account
Reports received
87
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
15
17% of reports
Injury reports
72
83% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 1 | 0 | 0 |
| Jan 24 | 3 | 1 | 1 | 0 |
| Feb 24 | 4 | 1 | 1 | 0 |
| Mar 24 | 3 | 3 | 0 | 0 |
| Apr 24 | 2 | 2 | 0 | 0 |
| May 24 | 1 | 1 | 0 | 0 |
| Jun 24 | 1 | 0 | 1 | 0 |
| Jul 24 | 1 | 1 | 0 | 0 |
| Aug 24 | 2 | 4 | 0 | 0 |
| Sep 24 | 2 | 1 | 0 | 0 |
| Oct 24 | 0 | 4 | 0 | 0 |
| Nov 24 | 1 | 1 | 0 | 0 |
| Dec 24 | 1 | 2 | 0 | 0 |
| Jan 25 | 0 | 2 | 0 | 0 |
| Feb 25 | 0 | 1 | 0 | 0 |
| Mar 25 | 0 | 3 | 0 | 0 |
| Apr 25 | 1 | 1 | 0 | 0 |
| May 25 | 0 | 2 | 0 | 0 |
| Jun 25 | 0 | 2 | 0 | 0 |
| Jul 25 | 0 | 2 | 0 | 0 |
| Aug 25 | 1 | 2 | 0 | 0 |
| Sep 25 | 0 | 3 | 0 | 0 |
| Oct 25 | 3 | 0 | 0 | 0 |
| Nov 25 | 2 | 4 | 0 | 0 |
| Dec 25 | 2 | 0 | 0 | 0 |
| Jan 26 | 0 | 5 | 0 | 0 |
| Feb 26 | 1 | 4 | 0 | 0 |
| Mar 26 | 0 | 4 | 0 | 0 |
| Apr 26 | 1 | 5 | 0 | 0 |
| May 26 | 3 | 2 | 0 | 0 |
| Jun 26 | 2 | 1 | 0 | 0 |
| Jul 26 | 1 | 2 | 0 | 0 |
| Aug 26 | 1 | 39 | 0 | 0 |
| Sep 26 | 2 | 3 | 0 | 0 |
| Oct 26 | 0 | 3 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
3 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- OPTIMIZER model CCM X11 implantable pulse generator (IPG) devices - Smart Mini and LiteOpen, Classified
Z-1173-2024 · Started Jan 5, 2024 · Posted by FDA Feb 22, 2024
Reason given: OPTIMIZER devices may cease to deliver CCM therapy if the device incorrectly detects a charging error. This may cause patients to experience heart failure symptoms similar to before implantation of the device.
Cause as FDA categorized it: Software design · Device type: Implantable Pulse Generator (QFV)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.